UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)


	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended July 31, 2026

	OR

	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from _______________ to _______________

Commission File Number: 0-15535

LAKELAND INDUSTRIES, INC.

(Exact name of Registrant as specified in its charter)


Delaware		13-3115216
(State or Other Jurisdiction of		(I.R.S. Employer
Incorporation or Organization)		Identification No.)

1525 Perimeter Parkway, Suite 325 Huntsville, AL		35806
(Address of Principal Executive Offices)		(Zip Code)

(Registrant's telephone number, including area code) (256) 350-3873

Securities registered pursuant to Section 12(b) of the Act:

     Title of each class

     Trading
Symbol(s)

     Name of each exchange
on which registered

     Common Stock

     LAKE

     NASDAQ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:


Large accelerated filer	☐	Accelerated filer	☒
Nonaccelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No x

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.


Class		Outstanding at September 4, 2026
Common Stock, $0.01 par value per share		9,931,346 Shares

LAKELAND INDUSTRIES, INC.

AND SUBSIDIARIES

FORM 10-Q

The following information of the Registrant and its subsidiaries is submitted herewith:


		Page
PART I - FINANCIAL INFORMATION:

Item 1.	Financial Statements (Unaudited)

	Condensed Consolidated Statements of Operations for the three and six months ended July 31, 2026 and 2025	3

	Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended July 31, 2026 and 2025	4

	Condensed Consolidated Balance Sheets as of July 31, 2026 and January 31, 2026	5

	Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended July 31, 2026 and 2025	6

	Condensed Consolidated Statements of Cash Flows for the six months ended July 31, 2026 and 2025	8

	Notes to Condensed Consolidated Financial Statements	9

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	25

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	31

Item 4.	Controls and Procedures	32

PART II - OTHER INFORMATION:

Item 1.	Legal Proceedings	34

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35

Item 5	Other Information	35

Item 6.	Exhibits	36

	Signature Pages	37

LAKELAND INDUSTRIES, INC.

AND SUBSIDIARIES

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

LAKELAND INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

($000’s except for share and per share information)


	Three Months Ended July 31,						Six Months Ended July 31,
	2026			2025			2026			2025
Net sales	$	50,139		$	52,496		$	97,555		$	99,242
Cost of goods sold		31,596			33,678			64,127			64,780
Gross profit		18,543			18,818			33,428			34,462
Operating expenses		20,636			19,283			39,700			39,561
Settlement of lease liability, net		(1,925	)		—			(1,925	)		—
Goodwill impairment		3,176			—			3,176			—
Gain on sale of certain assets		—			—			(6,467	)		—
Lease impairment		—			3,577			—			3,577
Operating loss		(3,344	)		(4,042	)		(1,056	)		(8,676	)
Other income, net		146			38			186			144
Interest expense		(525	)		(445	)		(1,139	)		(1,028	)
Loss before taxes		(3,723	)		(4,449	)		(2,009	)		(9,560	)
Income tax expense (benefit)		1,206			(5,215	)		2,551			(6,413	)
Net (loss) income	$	(4,929	)	$	766		$	(4,560	)	$	(3,147	)
Net (loss) income per common share:
Basic	$	(0.50	)	$	0.08		$	(0.46	)	$	(0.33	)
Diluted	$	(0.50	)	$	0.08		$	(0.46	)	$	(0.33	)
Weighted average common shares outstanding:
Basic		9,941,003			9,530,082			9,859,199			9,506,604
Diluted		9,941,003			10,093,855			9,859,199			9,506,604

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

LAKELAND INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

($000’s)


	Three Months Ended July 31,					Six Months Ended July 31,
	2026			2025		2026			2025
Net (loss) income	$	(4,929	)	$	766	$	(4,560	)	$	(3,147	)
Other comprehensive income:
Foreign currency translation adjustments		(1,199	)		2,145		(812	)		2,896
Comprehensive (loss) income	$	(6,128	)	$	2,911	$	(5,372	)	$	(251	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

LAKELAND INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(000’s except for share information)


	July 31,			January 31,
ASSETS	2026			2026
Current assets
Cash and cash equivalents	$	17,901		$	12,515
Accounts receivable, net of allowance for credit losses of $1,101 and $1,064 at July 31, 2026 and January 31, 2026, respectively		32,037			32,043
Inventories, net		74,931			82,542
Prepaid VAT and other taxes		3,077			2,429
Other current assets		8,685			4,657
Total current assets		136,631			134,186
Property and equipment, net		11,634			11,640
Operating leases right-of-use assets		9,975			11,248
Deferred tax assets		1,148			1,149
Goodwill		11,992			15,287
Intangible assets, net		30,179			31,724
Other assets		4,968			4,699
Total assets	$	206,527		$	209,933
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	17,920		$	15,565
Deferred revenue		5,199			—
Accrued compensation and benefits		5,976			4,984
Other accrued expenses		8,743			8,964
Income tax payable		2,528			1,802
Current portion of long-term debt		1,750			1,891
Current portion of operating lease liabilities		3,760			4,756
Total current liabilities		45,876			37,962
Deferred income taxes		2,116			2,198
Long-term debt		26,921			30,382
Long-term portion of operating lease liabilities		6,507			10,264
Total liabilities		81,420			80,806
Commitments and contingencies (Note 11)
Stockholders’ equity
Preferred stock, $0.01 par; authorized 1,500,000 shares (none issued)		—			—
Common stock, $0.01 par; authorized 20,000,000 shares; issued 11,268,067 and 11,164,336; outstanding 9,909,859 and 9,806,128 at July 31, 2026 and January 31, 2026, respectively		112			112
Treasury stock, at cost; 1,358,208 shares at July 31, 2026 and January 31, 2026, respectively		(19,979	)		(19,979	)
Additional paid-in capital		130,743			129,391
Retained earnings		19,297			23,857
Accumulated other comprehensive loss		(5,066	)		(4,254	)
Total stockholders' equity		125,107			129,127
Total liabilities and stockholders' equity	$	206,527		$	209,933

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

LAKELAND INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(UNAUDITED)

(000’s except for share information)


	Six Months Ended July 31, 2026
																		Accumulated
												Additional						Other
		Common Stock				Treasury Stock						Paid-in			Retained			Comprehensive
		Shares		Amount		Shares			Amount			Capital			Earnings			Loss			Total
Balance, January 31, 2026			11,164,336	$	112		(1,358,208	)	$	(19,979	)	$	129,391		$	23,857		$	(4,254	)	$	129,127
Net income			—		—		—			—			—			369			—			369
Other comprehensive income			—		—		—			—			—			—			387			387
Stock-based compensation:
Restricted stock issued			55,991		—		—			—			—			—			—			—
Restricted stock plan			—		—		—			—			800			—			—			800
Return of shares in lieu of payroll withholding			—		—		—			—			(158	)		—			—			(158	)
Balance, April 30, 2026			11,220,327	$	112		(1,358,208	)	$	(19,979	)	$	130,033		$	24,226		$	(3,867	)	$	130,525
Net loss			—		—		—			—			—			(4,929	)		—			(4,929	)
Other comprehensive income			—		—		—			—			—			—			(1,199	)		(1,199	)
Stock-based compensation:
Restricted stock issued			47,740		—		—			—			—			—			—			—
Restricted stock plan			—		—		—			—			819			—			—			819
Return of shares in lieu of payroll withholding			—		—		—			—			(109	)		—			—			(109	)
Balance, July 31, 2026			11,268,067	$	112		(1,358,208	)	$	(19,979	)	$	130,743		$	19,297		$	(5,066	)	$	125,107

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

LAKELAND INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(UNAUDITED)

(000’s except for share information)


	Six Months Ended July 31, 2025
																		Accumulated
												Additional						Other
		Common Stock				Treasury Stock						Paid-in			Retained			Comprehensive
		Shares		Amount		Shares			Amount			Capital			Earnings			Loss			Total
Balance, January 31, 2025			10,856,812	$	109		(1,358,208	)	$	(19,979	)	$	123,136		$	50,320		$	(6,960	)	$	146,626
Net loss			—		—		—			—			—			(3,913	)		—			(3,913	)
Other comprehensive income			—		—		—			—			—			—			751			751
Dividends ($0.03 per share)			—		—		—			—			—			(285	)		—			(285	)
Stock-based compensation:																						—
Restricted stock issued			15,739		—		—			—						—			—			—
Restricted stock plan			—		—		—			—			329			—			—			329
Return of shares in lieu of payroll withholding			—		—		—			—			(126	)		—			—			(126	)
Balance, April 30, 2025			10,872,551	$	109		(1,358,208	)	$	(19,979	)	$	123,339		$	46,122		$	(6,209	)	$	143,382
Net income			—		—		—			—			—			766			—		$	766
Other comprehensive income			—		—		—			—			—			—			2,145			2,145
Dividends ($0.03 per share)			—		—		—			—			—			(286	)		—			(286	)
Stock-based compensation:																						—
Restricted stock issued			36,728		—		—			—			—			—			—			—
Restricted stock plan			—		—		—			—			1,411			—			—			1,411
Return of shares in lieu of payroll withholding			—		—		—			—			(156	)		—			—			(156	)
Balance, July 31, 2025			10,909,279	$	109		(1,358,208	)	$	(19,979	)	$	124,594		$	46,602		$	(4,064	)		147,262

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

LAKELAND INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

($000’s)


	Six Months Ended July 31,
	2026			2025
Cash flows from operating activities:
Net loss	$	(4,560	)	$	(3,147	)
Adjustments to reconcile net loss to net cash used in operating activities
Deferred income taxes		(78	)		(10,279	)
Depreciation and amortization		2,690			2,406
Settlement of lease liability, net		(1,925	)		—
Stock based and restricted stock compensation		1,402			1,740
Gain on disposal of property and equipment		(9	)		(3	)
Gain on sale of certain assets		(6,467	)		—
Goodwill impairment		3,176			—
Lease impairments		—			3,577
Amortization of step-up in inventory basis		—			854
Change in operating assets and liabilities, net of effect of business acquisitions
Accounts receivable, net		(277	)		(2,589	)
Inventories		6,969			(6,163	)
Prepaid VAT and other taxes		(648	)		730
Other assets		(2,985	)		454
Accounts payable		2,476			1,846
Deferred revenue		5,199			—
Accrued expenses and other liabilities		1,982			1,146
Operating lease liabilities		(1,548	)		(232	)
Net cash provided by (used in) operating activities		5,397			(9,660	)
Cash flows from investing activities:
Purchases of property and equipment		(1,434	)		(2,130	)
Proceeds from sale of certain assets		5,066			—
Net cash provided by (used in) investing activities:		3,632			(2,130	)
Cash flows from financing activities:
Term loan borrowings		933			2,066
Payments on debt facilities		(33,883	)		(4,101	)
Credit line borrowings		29,480			13,830
Proceeds from employee stock purchase plan		215			—
Shares returned to pay employee taxes under restricted stock program		(267	)		(283	)
Dividends paid		—			(571	)
Net cash (used in) provided by financing activities		(3,522	)		10,941
Effect of exchange rate changes on cash and cash equivalents		(121	)		1,122
Net increase in cash and cash equivalents		5,386			273
Cash and cash equivalents at beginning of period		12,515			17,476
Cash and cash equivalents at end of period	$	17,901		$	17,749
Supplemental disclosure of cash flow information:
Cash paid for interest	$	1,139		$	1,024
Cash paid for taxes	$	2,123		$	1,692

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

LAKELAND INDUSTRIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Business

Lakeland Industries, Inc. and Subsidiaries, doing business as “Lakeland Fire + Safety” (“Lakeland,” the “Company,” “we,” “our” or “us”), manufacture and sell a comprehensive line of fire services and industrial protective clothing and accessories for the industrial and first responder markets. In addition, we provide decontamination, repair and rental services that complement our fire services portfolio. Our products are sold globally by our in-house sales teams, our customer service group, and authorized independent sales representatives to a strategic and selective global network of authorized distribution partners. Our authorized distributors supply end users across various industries, including integrated oil, chemical/petrochemical, automobile, transportation, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical and high-tech electronics manufacturers, as well as scientific, medical laboratories and the utilities industry. We also supply federal, state and local governmental agencies and departments, including fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control. Internationally, we sell to a mix of end-users directly and to industrial distributors, depending on the particular country and market. In addition to the United States (U.S.), sales are made into more than 50 foreign countries, the majority of which were into China, the European Economic Community ("EEC"), Canada, Chile, Argentina, Russia, Kazakhstan, Colombia, Mexico, Ecuador, India, Uruguay, Middle East, Southeast Asia, Australia, Hong Kong and New Zealand.

Basis of Presentation

The condensed consolidated financial statements of the Company are unaudited. These condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, that management considers necessary to fairly state the Company's results. Intercompany accounts and transactions have been eliminated. The results reported in these condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire fiscal year ending January 31, 2027, or for any future period. The January 31, 2026, Condensed Consolidated Balance Sheet data was derived from the audited Consolidated Balance Sheet as of that date but does not include all disclosures required by accounting principles generally accepted in the United States of America (U.S. GAAP). The accompanying condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto as of and for the years ended January 31, 2026 and 2025, included in our most recent annual report on Form 10-K filed on April 16, 2026.

In this Form 10-Q, (a) “FY” means fiscal year; thus, for example, FY27 refers to the fiscal year ending January 31, 2027, (b) “Q” refers to quarter; thus, for example, Q2 FY27 refers to the second quarter of the fiscal year ending January 31, 2027, (c) “Balance Sheet” refers to the unaudited condensed consolidated balance sheet, and (d) “Statement of Operations” refers to the unaudited condensed consolidated statement of operations.

Recently Issued and Adopted Accounting Standards

The Company considers the applicability and impact of all accounting standards updates (“ASUs”). Management periodically reviews new accounting standards that are issued.

Income Taxes

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This guidance requires a public entity to disclose in their rate reconciliation table additional categories of information about federal, state and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance also requires all entities to disclose annually income taxes paid (net of refunds received) disaggregated by federal (national), state and foreign taxes and to disaggregate the information by jurisdiction based on a quantitative threshold. This guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted, and this guidance should be applied prospectively but there is the option to apply it retrospectively. The Company prospectively adopted the provisions of this guidance in conjunction with our Form 10-K for our fiscal year ended January 31, 2026.

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU No. 2024-03 (“ASU 2024-03”), Disaggregation of Income Statement Expenses (“DISE”). ASU 2024-03 requires disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. As revised by ASU No. 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, the provisions of ASU 2024-03 are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. With the exception of expanding disclosures to include more granular income statement expense categories, we do not expect the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements taken as a whole.

Credit Losses

In July 2025, the FASB issued ASU No. 2025-05 (“ASU 2025-05”), Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. This guidance provides a practical expedient that entities may elect when estimating expected credit losses for current accounts receivable and current contract assets, allowing entities to assume that conditions as of the balance sheet date remain unchanged over the life of the asset. ASU 2025-05 is effective for annual periods beginning after December 15, 2025, with early adoption permitted. The Company adopted ASU 2025-05 during the six months ended July 31, 2026. The adoption of this guidance did not have a material effect on the Company's consolidated financial statements or disclosures.

Accounting for Internal-Use Software

In September 2025, the FASB issued ASU No. 2025-06 (“ASU 2025-06”), “Intangibles-Goodwill and Other Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.” This ASU removes references to prescriptive and sequential software development project stages and provides updated guidance intended to simplify the capitalization and expense evaluation for internal-use software. ASU 2025-06 is effective for fiscal years beginning after December 17, 2027, and interim reporting periods within those annual reporting periods, with early adoption permitted. This ASU may be applied prospectively, retrospectively, or with a modified transition approach. The Company is currently assessing the impact of adopting this standard on its consolidated financial statements.

Acquisitions

Acquisition of Arizona PPE Recon, Inc.

On September 15, 2025, the Company acquired 100% of U.S.-based Arizona PPE Recon, Inc. (“Arizona PPE”) for cash consideration of approximately $4.1 million, subject to post-closing adjustments and customary holdback provisions. Founded in 2016, Arizona PPE is the leading UL-certified independent services provider (“ISP”) for performing advanced decontamination, inspection and repairs on firefighting garments for the Arizona market, as well as providing educational and training classes to fire departments and personnel to help them implement and adhere to NFPA 1851 guidelines.

Arizona PPE’s operating results are included in our condensed consolidated financial statements from the acquisition date. The acquisition qualified as a business combination and was accounted for using the acquisition method of accounting. Arizona PPE’s operating results and assets, including acquired intangibles and goodwill, are reported as part of U.S. in our geographic segment reporting.

The following table summarizes the fair values of the Arizona PPE assets acquired and liabilities assumed at the date of the acquisition:


Net working capital acquired, including cash of $0.1 million	$	314
Property, plant and equipment		10
Right of use assets		399
Customer relationships		2,600
Trade names		190
Goodwill		987
Lease Liabilities		(399	)
Total net assets acquired	$	4,101

Assets acquired and liabilities assumed in connection with the acquisition were recorded at estimated fair values. Estimated fair values were determined by management, based in part on an independent valuation performed by a third-party valuation specialist. The valuation methods used to determine the estimated fair value of intangible assets included the excess earnings approach for customer relationships using customer inputs and contributory charges and the relief from royalty method for trade names. Several significant assumptions and estimates were involved in the application of these valuation methods, including forecasted sales volumes and prices, royalty rates, costs to produce, tax rates, capital spending, discount rates, attrition rates and working capital changes. Cash flow forecasts were generally based on Arizona PPE’s pre-acquisition forecasts and management estimates. Identifiable intangible assets with finite lives are subject to amortization over their estimated useful lives. The customer relationships and trade names and trademarks acquired in the Arizona PPE transaction are being amortized over periods of 13 years and 10 years, respectively, and are deductible for tax purposes.

Goodwill is calculated as the excess of the purchase price over the estimated fair value of net assets acquired and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Among the factors that contributed to a purchase price in excess of the estimated fair value of the net tangible and intangible assets acquired were the acquisition of an assembled workforce, the expected synergies and other benefits that we believe will result from combining the operations of Arizona PPE with our operations. Goodwill related to the Arizona PPE acquisition is deductible for tax purposes.

Acquisition of California PPE Recon, Inc.

On September 15, 2025, the Company acquired 100% of U.S.-based California PPE Recon, Inc. (“California PPE”) for a combination of approximately $2.4 million in cash consideration and 227,728 unregistered shares of the Company's common stock with an estimated fair value of $3.3 million at the date of acquisition, subject to post-closing adjustments and customary holdback provisions. Founded in 2022, California PPE is a leading and rapidly expanding UL-certified ISP in the California firefighting services market, one of the largest fire markets in the U.S. It also provides advanced decontamination, repair, and inspection of firefighting personal protective equipment, along with rental services and sales of cleaning detergents, extractors, and dryers.

California PPE’s operating results are included in our condensed consolidated financial statements from the acquisition date. The acquisition qualified as a business combination and was accounted for using the acquisition method of accounting. California PPE’s operating results and assets, including acquired intangibles and goodwill, are reported as part of U.S. in our geographic segment reporting.

The following table summarizes the fair values of the California PPE assets acquired and liabilities assumed at the date of the acquisition:


Net working capital acquired, including cash of $0.2 million	$	681
Property, plant and equipment		746
Right of use assets		198
Customer relationships		3,600
Trade names		210
Goodwill		1,438
Lease liabilities		(198	)
Other liabilities assumed		(914	)
Total net assets acquired	$	5,761

Assets acquired and liabilities assumed in connection with the acquisition were recorded at estimated fair values. Estimated fair values were determined by management, based in part on an independent valuation performed by a third-party valuation specialist. The valuation methods used to determine the estimated fair value of intangible assets included the excess earnings approach for customer relationships using customer inputs and contributory charges and the relief from royalty method for trade names. Several significant assumptions and estimates were involved in the application of these valuation methods, including forecasted sales volumes and prices, royalty rates, costs to produce, tax rates, capital spending, discount rates, attrition rates and working capital changes. Cash flow forecasts were generally based on California PPE’s pre-acquisition forecasts and management estimates. Identifiable intangible assets with finite lives are subject to amortization over their estimated useful lives. The customer relationships and trade names and trademarks acquired in the California PPE transaction are being amortized over periods of 13 years and 10 years, respectively.

Goodwill is calculated as the excess of the purchase price over the estimated fair value of net assets acquired and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Among the factors that contributed to a purchase price in excess of the estimated fair value of the net tangible and intangible assets acquired were the acquisition of an assembled workforce, the expected synergies and other benefits that we believe will result from combining the operations of California PPE with our operations. A portion of goodwill related to the California PPE acquisition is deductible for tax purposes.

The following unaudited pro forma information presents our combined results of operations as if the Arizona PPE and California PPE acquisitions had occurred at the beginning of FY26. The unaudited pro forma combined financial information was prepared using the acquisition method of accounting under existing U.S. GAAP. The Company has been treated as the acquirer. The unaudited pro forma financial information was prepared to give effect to events that are (1) directly attributable to the acquisition, (2) factually supportable, and (3) expected to have a continuing impact on the combined company's results. There were no material transactions between the Company and the acquired entities during the periods presented that are required to be eliminated. The unaudited pro forma combined financial information does not reflect cost savings, operating synergies or revenue enhancements that the combined companies may achieve or the costs to integrate the operations or the costs necessary to achieve cost savings, operating synergies or revenue enhancements.

Pro forma combined financial information (Unaudited)


(in thousands, except per share amounts)	Three Months Ended July 31, 2025		Six Months Ended July 31, 2025
Net sales	$	53,678	$	101,737
Net income	$	807	$	(2,936	)
Basic earnings per share	$	0.08	$	(0.31	)
Diluted earnings per share	$	0.08	$	(0.31	)

The unaudited pro forma combined financial information is presented for information purposes only and is not intended to represent or be indicative of the combined results of operations or financial position that we would have reported had the acquisition been completed as of the date and for the period presented and should not be taken as representative of our consolidated results of operations or financial condition following the acquisition. In addition, the unaudited pro forma combined financial information is not intended to project the future results of the combined company.

Inventories

Inventories consist of the following (in $000s):


	July 31, 2026			January 31, 2026
Raw materials	$	34,820		$	40,406
Work-in-process		2,087			2,465
Finished goods		43,521			44,380
Excess and obsolete adjustments		(5,497	)		(4,709	)
Total inventories	$	74,931		$	82,542

During the first quarter of FY27, the Company completed the sale of its High Performance and High Visibility inventory and certain intellectual property associated with that inventory for total net cash consideration of $13.2 million. The consideration included a $1.4 million escrow receivable recorded in other assets on the condensed consolidated balance sheets. The Company recognized a gain on the sale of $6.5 million.

Cash proceeds received related to the sale of inventory has been reflected as deferred revenue in the condensed consolidated balance sheets as of July 31, 2026 due to the Company’s agreement with the buyer to continue to manufacture and warehouse the associated inventory. Deferred revenue will be recognized in the condensed consolidated statement of operations as the Company manufactures and ships the inventory to the buyer. During the three months ended July 31, 2026, $1.4 million of previously deferred revenue was recognized and offset against the related inventory writedown with no impact to the condensed consolidated statement of operations.

Goodwill and Intangible Assets, Net

Changes in the carrying amount of goodwill for the six months ended July 31, 2026 and 2025, are as follows (in $000s):


	2026			2025
Balance at January 31,	$	15,287		$	16,240
Currency translation		(119	)		1,147
Impairment		(3,176	)		—
Measurement period adjustments		—			(2,340	)
Balance at July 31,	$	11,992		$	15,047

During the three months ended July 31, 2026, the Company identified indicators of impairment for its LHD reporting unit within the Europe geographic segment, primarily due to lower-than-expected financial performance and projected cash flows. As a result, the Company performed an interim quantitative goodwill impairment assessment to evaluate the goodwill of the LHD reporting unit using a discounted cash flow methodology. Based on the results of the interim quantitative impairment assessment, the Company recorded a goodwill impairment expense of $3.2 million, representing the remaining goodwill associated with this reporting unit. Following recognition of the impairment charge, accumulated goodwill impairment charges associated with the LHD reporting unit were $5.8 million, and no goodwill remains allocated to the LHD reporting unit.

Changes in intangible assets, net, during the six months ended July 31, 2026 and 2025, are as follows (in $000s):


	2026			2025
Balance at January 31,	$	31,724		$	25,503
Amortization		(1,341	)		(785	)
Currency translation		(204	)		1,505
Measurement period adjustments		—			(216	)
Balance at July 31,	$	30,179		$	26,007

Amortization expense was $0.7 million and $0.4 million in the three months ended July 31, 2026 and 2025, respectively, and $1.3 million and $0.8 million in the six months ended July 31, 2026 and 2025, respectively, and was included in operating expenses on the condensed consolidated statements of operations.

Long-Term Debt

Revolving Credit Facility

On June 25, 2020, the Company entered into a Loan Agreement (the “Original Loan Agreement”) with Bank of America, N.A. (“Lender”), as amended by Amendment No. 1 to the Loan Agreement, dated June 18, 2021 (“Amendment No. 1”), Amendment No. 2 to the Loan Agreement, dated March 3, 2023 (“Amendment No. 2”), Amendment No. 3 to the Loan Agreement, dated November 30, 2023 (“Amendment No. 3”), Amendment No. 4 to the Loan Agreement, dated March 28, 2024 (“Amendment No. 4”), Amendment No. 5 to the Loan Agreement, dated December 12, 2024 (“Amendment No. 5”), and Amendment No. 6 to the Loan Agreement, dated July 7, 2025 (“Amendment No. 6” and, collectively with Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, and Amendment No. 5, the “Loan Agreement Amendments”; and the Original Loan Agreement, as amended by the Loan Agreement Amendments, the “Amended Loan Agreement”).

The Amended Loan Agreement provides the Company with a secured revolving credit facility of up to $40.0 million of borrowings (giving effect to the reduction of such limit following the application of the net proceeds from the Company's January 2025 equity issuance). The revolving credit facility includes a $10.0 million letter of credit sub-facility. The credit facility matures on December 12, 2029.

Borrowings under the revolving credit facility bear interest at a rate per annum equal to the sum of (i) the greater of the daily Secured Overnight Financing Rate (“SOFR”) or an index floor of 1% plus (ii) the Applicable Rate (as defined in the Amended Loan Agreement). The Applicable Rate is based upon a funded debt to EBITDA ratio (discussed below) and includes four different levels constituting a SOFR margin range from 1.25% to 2.00%. All outstanding principal and unpaid accrued interest under the revolving credit facility is due and payable on the maturity date. On a one-time basis, and subject to there not existing an event of default, the Company may elect to convert up to $5.0 million of the then outstanding principal of the revolving credit facility to a term loan facility with an assumed amortization of 15 years and the same interest rate and maturity date as the revolving credit facility. The Amended Loan Agreement provides for a fee on any difference between the line of credit commitment and the amount of credit it actually uses, determined by the daily amount of credit outstanding during the specified period. Such fee is calculated at the Applicable Rate and is payable quarterly.

The Company made certain representations and warranties to the Lender in the Amended Loan Agreement that are customary for credit arrangements of this type. The Company also agreed to maintain, as of the end of each fiscal quarter a minimum “basic fixed charge coverage ratio” (as defined in the Amended Loan Agreement) of at least 1.20x and a “funded debt to EBITDA ratio” (as defined in the Amended Loan Agreement) not to exceed 3.5x (with step-downs to 3.25x and 3.0x on February 1, 2026 and February 1, 2027, respectively), in each case for the trailing 12-month period ending with the applicable quarterly reporting period. In addition, the Company has agreed to maintain a springing “asset coverage ratio” (as defined in the Amended Loan Agreement) of at least 1.10x, but only to the extent that the maximum funded debt to EBITDA ratio exceeds 3.25x at any reporting period. The Company was in compliance with all of its debt covenants as of July 31, 2026.

The Company also agreed to certain negative covenants under the Amended Loan Agreement that are customary for credit arrangements of this type, including restrictions regarding the ability of the Company and/or its subsidiaries to conduct business, grant liens, make certain investments, and incur additional indebtedness, which negative covenants are subject to certain exceptions. Moreover, the Amended Loan Agreement contains restrictions on the Company’s ability to enter into mergers and other business combination transactions and to purchase or acquire other businesses or their assets, although the Company may purchase a business or its assets without the consent of the Lender if the aggregate amount of consideration paid for by the Company is less than $26.0 million for any individual acquisition or $36.0 million on a cumulative basis for all such acquisitions or purchases subsequent to the date of Amendment No. 5. The Amended Loan Agreement also authorizes the Company to enter into additional lines of credit or incur liabilities in connection with the acquisitions of foreign subsidiaries in foreign countries where the Lender lacks a physical presence (such amounts not to exceed $10.0 million in the aggregate).

The Amended Loan Agreement contains customary events of default that include, among other things (subject to any applicable cure periods and materiality qualifier), non-payment of principal, interest or fees, defaults under related agreements with the Lender, cross-defaults under agreements for other indebtedness, violation of covenants, inaccuracy of representations and warranties, bankruptcy and insolvency events, material judgments and material adverse change. Upon the occurrence of an event of default, the Lender may terminate all loan commitments, declare all outstanding indebtedness owing under the Amended Loan Agreement and related documents to be immediately due and payable, and may exercise its other rights and remedies provided for under the Amended Loan Agreement.

In connection with the Amended Loan Agreement, the Company entered into with the Lender (i) a security agreement dated June 25, 2020, pursuant to which the Company granted to the Lender a first priority perfected security interest in substantially all of the personal property and the intangibles of the Company, and (ii) a pledge agreement, dated June 25, 2020, pursuant to which the Company granted to the Lender a first priority perfected security interest in the stock of its subsidiaries (limited to 65% of those subsidiaries that are considered “controlled foreign subsidiaries” as set forth in the Internal Revenue Code and regulations).

As of July 31, 2026, the Company had no borrowings outstanding on the letter of credit sub-facility and borrowings of $24.9 million outstanding under the revolving credit facility, and there was $15.1 million of additional available credit under the Loan Agreement. As of January 31, 2026, the Company had no borrowings outstanding on the letter of credit sub-facility and borrowings of $28.5 million outstanding under the revolving credit facility, and there was $11.5 million of additional available credit under the Loan Agreement. The interest rate on outstanding borrowings was 5.26% at July 31, 2026 and 5.76% at January 31, 2026.

Lakeland UK Borrowings

On December 31, 2014, the Company and Lakeland Industries Europe, Ltd. (“Lakeland UK”), a wholly owned subsidiary of the Company, amended the terms of its existing line of credit facility with HSBC Bank to provide for (i) a one-year extension of the maturity date of the existing financing facility to December 19, 2016, (ii) an increase in the facility limit from £1.3 million (approximately $1.9 million, based on exchange rates at time of closing) to £1.5 million (approximately $2.3 million, based on exchange rates at time of closing), and (iii) a decrease in the annual interest rate margin from 3.46% to 3.0%. In addition, pursuant to a letter agreement dated December 5, 2014, the Company agreed that £0.4 million (approximately $0.6 million, based on exchange rates at the time of closing) of the note payable by Lakeland UK to the Company shall be subordinated in priority of payment to the subsidiary’s obligations to HSBC under the financing facility. This agreement has been subsequently amended with the most recent amendment dated March 8, 2022. The cumulative result of the amendments through March 8, 2022, reflects a reduction of the service charge to 0.765%. The agreement can be terminated with three months’ notice. There were no borrowings outstanding under this facility at July 31, 2026 and January 31, 2026.

Pacific Helmets Borrowings

Pacific Helmets has a term loan facility with the Bank of New Zealand. The facility includes two term loans. The first term loan of 1.5 million NZD matured on December 17, 2025, carried an interest rate of 2.3% per annum and required monthly payments of 19,350.27 NZD with the outstanding balance due upon maturity. This term loan was repaid in full during FY26. The second term loan of 0.5 million NZD matures on November 18, 2026, carries an interest rate of 8.07% per annum and requires monthly payments of 10,545 NZD with the outstanding balance due upon maturity. As of July 31, 2026 and January 31, 2026, the outstanding balance under the term loans was less than $0.1 million and $0.1 million, respectively.

Jolly Borrowings

On May 9, 2024, Jolly entered into a term loan agreement for 1.5 million EUR to support working capital requirements with Banca Intesa Spa. The term loan matures on March 31, 2027, and carries an interest rate of 5.42%. The term loan is being repaid in 11 quarterly installments of 0.1 million EUR. The loan is guaranteed by SACE S.p.A., the Italian state-owned export credit finance agency.

On March 6, 2025, Jolly entered into a term loan agreement for 2.0 million EUR to support working capital requirements with Banca Intesa Spa. The term loan matures on September 30, 2028, and carries an interest rate with a fixed rate portion of 1.45% and a variable rate portion based on the three-month EURIBOR rate. The interest rate at July 31, 2026 was 3.94%. The term loan will be repaid in 11 quarterly installments of 0.2 million EUR, beginning September 30, 2025. Interest payments are made quarterly. The loan is guaranteed by SACE S.p.A., the Italian state-owned export credit finance agency.

As of July 31, 2026 and January 31, 2026, the outstanding balance under the term loans was $1.9 million and $2.7 million, respectively.

On May 4, 2026, Jolly entered into a revolving export financing credit facility for 1.0 million EUR to support working capital requirements with Banca Monte Dei Paschi Di Siena S.p.A. The facility is available on a revolving basis and remains in effect until revoked by either party. Borrowings under the facility bear interest at a variable rate based on six-month Euribor plus 0.50%. The applicable interest rate as of July 31, 2026 was 3.124%. Interest payments are made quarterly. As of July 31, 2026, the outstanding balance under the facility was $0.8 million.

LHD Borrowings

Prior to the Company’s acquisition, LHD secured a federally guaranteed term loan of 0.8 million EUR from Commerzbank AG under the “KfW Quick Loan 2020” program, launched by the German government in 2020 to support small and medium-sized enterprises affected by the COVID-19 crisis. Repayments of the loan, which matures on June 30, 2030, are made in quarterly installments of 25,000 EUR. The loan carries an interest rate of 3% per annum, with interest payments being due in arrears at the end of each quarter. As of July 31, 2026 and January 31, 2026, the outstanding balance was $0.5 million. LHD also had other borrowings outstanding of approximately $0.3 million and $0.2 million as of July 31, 2026 and January 31, 2026, respectively.

Veridian Borrowings

Prior to the Company’s acquisition, in February 2024, Veridian secured a term loan with U.S. Bank for a piece of equipment. The loan is for 60 months with monthly payments of approximately $8,000. The interest rate on the loan is 5.13%. As of July 31, 2026 and January 31, 2026, the outstanding balance was $0.2 million and $0.3 million, respectively.

Approximate maturities of our term loans over the next five years from July 31, 2026, are $1.7 million in FY27, $1.3 million in FY28, $0.5 million in FY29, $0.2 million in FY30, $0.1 million in FY31 and $24.9 million thereafter.

Concentration of Risk

Credit Risk

Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents, and trade receivables. The concentration of credit risk with respect to trade receivables is generally diversified due to the large number of entities comprising the Company’s customer base and their dispersion across geographic areas principally within the U.S. The Company routinely addresses the financial strength of its customers and, as a consequence, believes that its receivable credit risk exposure is limited. The Company does not require customers to post collateral.

The Company maintains foreign cash deposits with various financial institutions located in Asia, Europe, Latin America and Oceania. These depositories include both multinational banks and locally regulated institutions. The Company monitors the creditworthiness of its foreign financial depositories using credit ratings and other relevant financial information, which may vary by country. Additionally, cash balances in banks in the U.S. are insured by the Federal Deposit Insurance Corporation subject to certain limitations. As of July 31, 2026, approximately $1.7 million was held in U.S. bank accounts, and approximately $16.2 million was held in foreign bank accounts, of which $17.1 million was uninsured. As of January 31, 2026, approximately $1.5 million was held in U.S. bank accounts and approximately $11.0 million was held in foreign bank accounts, of which $11.7 million was uninsured.

Stockholders’ Equity

On June 21, 2017, the stockholders of the Company approved the Lakeland Industries, Inc. 2017 Equity Incentive Plan (the “2017 Plan”). The executive officers and all other employees and directors of the Company, including its subsidiaries, were eligible to participate in the 2017 Plan until it was replaced by the 2026 Plan (as defined below). The 2017 Plan was administered by the Compensation Committee of the Board of Directors (the “Committee”), except that with respect to all non-employee directors, the Committee was deemed to include the full Board. The 2017 Plan provided for the grant of equity-based compensation in the form of stock options, restricted stock, restricted stock units, performance shares, performance units, or stock appreciation rights (“SARs”).

On June 16, 2026, the stockholders of the Company approved the Lakeland Industries, Inc. 2026 Equity Incentive Plan (the “2026 Plan”), which replaced the 2017 Plan upon such approval by Lakeland’s stockholders. The executive officers and all other employees and directors of the Company, including its subsidiaries, are eligible to participate in the 2026 Plan. The 2026 Plan is administered by the Committee, except that with respect to all non-employee directors, the Committee shall be deemed to include the full Board. The 2026 Plan provides for the grant of equity-based compensation in the form of stock options, restricted stock, restricted stock units, performance shares, performance units or SARs. Upon the effectiveness of the 2026 Plan, no further grants have been or will be made under the 2017 Plan.

An aggregate of 700,000 shares of the Company’s common stock are currently authorized for issuance under the 2026 Plan, subject to adjustment as provided in the 2026 Plan for stock splits, dividends, distributions, recapitalizations and other similar transactions or events. If any shares subject to an award are forfeited, expire, lapse or otherwise terminate without issuance of such shares (including any shares subject to an award under a Prior Plan (as defined in the 2026 Plan)), such shares shall, to the extent of such forfeiture, expiration, lapse or termination, again be available for issuance under the 2026 Plan.

The Company recognized total stock-based compensation costs, which are reflected in operating expenses (in $000’s):


	Three Months Ended July 31,				Six Months Ended July 31,
	2026		2025		2026		2025
2017 and 2026 Plans:
Total restricted stock and stock option programs	$	602	$	428	$	1,402	$	1,740
Total income tax expense recognized for stock-based compensation arrangements	$	126	$	90	$	294	$	365

Restricted Stock and Restricted Stock Units

Under the 2017 Plan and 2026 Plan, as described above, the Company awarded performance-based and service-based shares of restricted stock and restricted stock units to eligible employees and directors. The following table summarizes the activity under the 2017 Plan and the 2026 Plan, as applicable, for the six months ended July 31, 2026 and 2025, respectively. This table reflects the amount of awards granted at the number of shares that would be vested if the Company were to achieve the target performance level under the then-outstanding performance-based grants.

Changes in performance-based and service-based shares outstanding during the six months ended July 31, 2026 are as follows:


	Performance- Based			Service- Based			Unrestricted Stock Awards			Total			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2026		265,158			212,106			—			477,264		$	20.84
Awarded		39,470			146,182			12,944			198,596		$	10.40
Vested		(7,613	)		(84,747	)		(12,944	)		(105,304	)	$	10.40
Forfeited		(1,846	)		(1,696	)		—			(3,542	)
Outstanding at July 31, 2026		295,169			271,845			—			567,014		$	20.46

Changes in performance-based and service-based shares outstanding during the three and six months ended July 31, 2025 are as follows:


	Performance- Based			Service- Based			Unrestricted Stock Awards			Total			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2025		69,670			182,135			—			251,805		$	17.36
Awarded		265,874			127,076			27,258			420,208		$	16.12
Vested		(3,304	)		(31,393	)		(27,258	)		(61,955	)	$	16.18
Forfeited		(29,485	)		(16,801	)		—			(46,286	)
Outstanding at July 31, 2025		302,755			261,017			—			563,772		$	17.62

For performance-based awards granted in FY23, FY24 and FY25, the actual number of shares of common stock of the Company, if any, to be earned by the award recipients is determined over a three-year performance measurement period based on measures determined in advance by the Compensation Committee of the Board of Directors of the Company. For the 2022 grants, the performance measures include Earnings Before Interest Taxes Depreciation and Amortization (“EBITDA”) margin, revenue growth, and return on invested capital. Performance measures for the 2023 grants are revenue growth, EBITDA margin and return on invested capital. The performance measures for the April 2024 grants are aggregate revenue during FY25, FY26 and FY27, EBITDA margin and free cash flow margin.

With respect to performance-based awards granted in May 2025, the performance measures are the Company’s total revenue, the Company’s fire segment revenue, and its adjusted EBITDA. Each of these metrics will be independently measured against Minimum, Target, and Maximum performance targets established by the Compensation Committee, against which the Company’s performance will be measured on an annual basis at the end of each fiscal year beginning January 31, 2029 through January 31, 2031. Two additional performance-based awards using the same framework as the May 2025 performance-based awards were granted in May 2026 to two recipients in connection with their respective appointments as executive officers of the Company.

The performance-based awards granted in July 2025 were granted to officers who elected to receive such awards in lieu of a portion of their short-term incentive cash compensation for FY26 and the performance measures for such awards were measured following the end of FY26 and included annual revenue, adjusted EBITDA, free cash flow margin and individual executive goals. None of the performance-based awards granted in July 2025 were earned and thus no shares of common stock were issued to the executive officers. In September 2025, the Company granted a one-time award to a recipient consisting of service-based and performance-based awards. The performance measures for the performance-based award will be measured following the end of FY29 and include annual revenue, Fire Services revenue and adjusted EBITDA.

For all performance-based awards, the performance targets have been set for each of the Minimum, Target, and Maximum levels. The actual performance amount achieved is determined by the Compensation Committee and may be adjusted for items determined to be unusual in nature or infrequent in occurrence, at the discretion of the Compensation Committee.

In May 2026, the Company granted service-based restricted stock awards to two members of the Board of Directors who elected to receive a portion of their board compensation in equity rather than cash. The awards vested immediately upon grant and may not be sold for one year following the grant date.

The fair value for performance and service-based awards is equal to the closing price of our stock price on the grant date. The compensation cost is based on the fair value at the grant date, is recognized over the requisite service period using the straight-line method and is periodically adjusted for the probable number of shares to be awarded. As of July 31, 2026, unrecognized stock-based compensation expense totaled $5.0 million pursuant to the 2017 Plan or the 2026 Plan, as applicable, based on outstanding awards under such Plans. This expense is expected to be recognized over approximately 2.2 years.

Stock Repurchase Program

On April 7, 2022, the Board of Directors authorized a stock repurchase program under which the Company may repurchase up to $5.0 million of its outstanding common stock, which became effective upon the completion of a prior share repurchase program. On December 1, 2022, the Board of Directors authorized an increase in the Company’s stock repurchase program, under which the Company may repurchase up to an additional $5.0 million of its outstanding common stock.

No shares were repurchased during Q2 FY27, leaving $5.0 million remaining under the share repurchase program at July 31, 2026. The share repurchase program has no expiration date but may be terminated by the Board of Directors at any time.

Income Taxes

The Company’s provision for income taxes for the three and six months ended July 31, 2026 and 2025 is based on the estimated annual effective tax rate, in addition to discrete items.

The Company’s effective tax rate for the three and six months ended July 31, 2026 was tax expense of 32.4% and tax expense of 127.0%, respectively. Both differ from the U.S. federal statutory rate of 21% primarily as a result of a valuation allowance against the Company’s U.S. operations. The Company's effective tax rate for the three and six months ended July 31, 2025 was a tax benefit of 117.2% and a tax benefit of 67.1%, respectively. Both differ from the U.S. federal statutory rate of 21%, primarily due to the forecasted allocation of income for the current fiscal year and from the mix of jurisdictional income at differing statutory rates.

The Company records net deferred tax assets to the extent the Company believes these assets will more likely than not be realized. The valuation allowance was $19.9 million and $18.3 million as of July 31, 2026 and January 31, 2026, respectively. The increase in the valuation allowance for the six months ended July 31, 2026, was treated as a component of the estimated annual effective tax rate.

The Company continually reviews the adequacy of its valuation allowance and recognizes the benefits of deferred tax assets only as the reassessment indicates that it is more likely than not that the deferred tax assets will be realized in accordance with ASC 740, Income Taxes. Due to the declines in revenue and profitability in prior periods and the weighing of all positive and negative objective evidence considered, the Company has limited ability to rely on subjective factors, including projected future growth, in evaluating whether its deferred tax assets will be realized. As such, the Company previously determined in FY2026 that it was no longer able to conclude that it is more likely than not that its U.S. deferred tax assets will be realized. The amount of the deferred tax assets considered realizable, however, could be adjusted in future periods in the event sufficient evidence is present to support a conclusion that it is more likely than not that all or a portion of its U.S. deferred tax assets will be realized.

With the exception of our UK and China subsidiaries for which we accrue relevant deferred tax impacts related to non-indefinitely reinvested cash, we consider the excess of the amount for financial reporting over the tax basis (including undistributed and previously taxed earnings) of investments in our other foreign subsidiaries as of July 31, 2026 to be indefinitely reinvested in the foreign jurisdictions on the basis of our specific plan for reinvestment and estimates that future U.S. cash generation will be sufficient to meet future U.S. cash needs. Therefore, we have not provided for deferred taxes related to such excess or the relevant portions thereof and disclosed that the determination of any deferred taxes related to this excess is not practicable in those permanently reinvested jurisdictions. We have made no changes to our policy on indefinite reinvestment during the three months ended July 31, 2026. During the three months ended July 31, 2026, the Company paid a dividend from its operations in China to the U.S. parent entity of $2.5 million, of which $0.3 million was remitted for withholding taxes in China that were previously accrued for under the Company’s current repatriation policy.

On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was enacted into law in the U.S. The OBBBA contains various changes to key U.S. federal income tax laws. The Company does not expect a material impact to its overall income tax provision as a result of this newly enacted legislation.

10.

Net (Loss) Income Per Share

The following table sets forth the computation of basic and diluted net (loss) income per share as follows (in $000s except share and per share amounts):


	Three Months Ended July 31,					Six Months Ended July 31,
	2026			2025		2026			2025
Numerator:
Net (loss) income	$	(4,929	)	$	766	$	(4,560	)	$	(3,147	)
Denominator:
Denominator for basic net (loss) income per share (weighted-average shares which exclude 1,358,208 treasury shares for the periods ended July 31, 2026 and 2025)		9,941,003			9,530,082		9,859,199			9,506,604
Effect of dilutive securities from restricted stock plan		—			563,773		—			—
Denominator for diluted net (loss) income per share (adjusted weighted average shares)		9,941,003			10,093,855		9,859,199			9,506,604
Basic net (loss) income per share	$	(0.50	)	$	0.08	$	(0.46	)	$	(0.33	)
Diluted net (loss) income per share	$	(0.50	)	$	0.08	$	(0.46	)	$	(0.33	)

For the three months ended July 31, 2026, 0.5 million shares of unvested restricted stock awards were excluded from the calculation of diluted earnings per share due to their anti-dilutive effect. For the six months ended July 31, 2026 and 2025, 0.5 million and 0.4 million shares, respectively, of unvested restricted stock awards were excluded from the calculation of diluted earnings per share due to their anti-dilutive effect. There were no shares of unvested restricted stock awards excluded from the calculation of diluted earnings per share for the three months ended July 31, 2025.

11.

Contingencies

Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and legal counsel assess such contingent liabilities, which inherently involve an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been or is probable of being incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.

In June 2025, the Company initiated legal action against the landlord seeking rescission of the lease due to unremediated structural defects on the newly constructed facility in Monterrey, Mexico that prevented the Company from effectively utilizing the facility for its intended purpose. In July 2026, the Company reached a settlement with the landlord that terminated the lease in its entirety and concluded the related litigation.

As a result of the settlement and lease termination, the Company released the remaining lease liability and recognized a gain of approximately $1.9 million during the three months ended July 31, 2026.

The Company is involved in various claims, actions, and legal proceedings arising in the ordinary course of business, including multiple lawsuits involving allegations that plaintiffs were exposed to Per- and polyfluoroalkyl substances (“PFAS”) during their careers as firefighters. Plaintiffs allege personal injuries from exposure to PFAS contained in aqueous film forming foam (“AFFF”) and firefighter turnout gear. The vast majority of these cases are pending in the AFFF multi-district litigation consolidated in the United States District Court of South Carolina, Charleston Division. The Company is also named alongside several defendants in a class action regarding firefighter turnout gear pending in the United States District Court of Connecticut, styled as Uniformed Professional Fire Fighters Association of Connecticut et al. v. 3M Company et al., Case No. 3:24-CV-01101. The case seeks certification of a fire fighter class, a nationwide purchaser class, and a Connecticut purchaser subclass. On August 18, 2026, the Judicial Panel on Multidistrict Litigation established a separate multidistrict litigation in the United States District Court for the District of Minnesota for non-AFFF firefighter turnout gear claims, and the above-referenced Connecticut action is now subject to a conditional transfer order that, absent other action by the Panel, is expected to result in its transfer to that proceeding for coordinated pretrial proceedings. The Company is also a defendant in Crady v. 3M Co., a personal injury action pending in Missouri state court in which Jason Crady and his wife allege that occupational exposure to PFAS-containing firefighter gear and equipment caused his thyroid cancer and related damages. Because the Crady action was remanded to state court, it is not eligible for transfer to the new multi-district litigation. The Company’s exposure in these matters to losses, if any, is not reasonably estimable at this time.

A putative class action was filed on February 23, 2026 (and subsequently amended on July 24, 2026) against Lakeland Industries, Inc. and certain current and former senior officers in the United States District Court for the Southern District of New York, purportedly on behalf of a class of the Company's investors who purchased or otherwise acquired our publicly traded securities between September 4, 2024 and December 9, 2025. Lead counsel was appointed on May 15, 2026. The Company's deadline to respond to the amended complaint is September 24, 2026. The complaint alleges that the defendants made materially false and misleading statements about the Company’s business and operations, including an alleged failure to account properly for intercompany transactions. Plaintiffs bring their claims under Sections 10(b) and 20(a) of the Exchange Act. The Company intends to vigorously defend against these actions, which the Company believes to be without merit. The potential impact of these actions, which seek unspecified damages, attorneys’ fees and expenses, is uncertain.

Lakeland Industries, Inc. is a nominal defendant in a derivative action filed on May 4, 2026 in the Southern District of New York by ES Trust against Lakeland’s officers and directors, captioned ES Trust vs. James Jenkins, et al. The case alleges violations of Section 14(a) of the Exchange Act and that the Company’s officers and directors breached their fiduciary duties in permitting the allegedly wrongful conduct to occur. The class action and derivative cases have been identified as related and assigned to the same judge, and the parties to the derivative case have agreed to stay its proceedings pending the outcome of a motion to dismiss in the putative class action. The derivative case is in its early stage, and a potential loss cannot yet be estimated.

General litigation contingencies

The Company is involved in various litigation proceedings arising during the normal course of business which, in the opinion of the management of the Company, will not have a material effect on the Company’s financial position, results of operations or cash flows; however, there can be no assurance as to the ultimate outcome of these matters. As of July 31, 2026 and January 31, 2026, to the best of the Company’s knowledge, there were no significant outstanding claims or litigation.

12.

Segment Reporting

Domestic and international sales are as follows in millions of dollars:


	Three Months Ended July 31,				Six Months Ended July 31,
(in millions)	2026		2025		2026		2025
Domestic	$	21.4	$	22.1	$	41.5	$	42.8
International		28.7		30.4		56.0		56.4
Total Sales	$	50.1	$	52.5	$	97.5	$	99.2

The Company is organized into seven geographical operating segments that are based on management responsibilities: U.S. Operations (including the corporate office), Europe, Mexico, Asia, Canada, Latin America and Other Foreign.

Gross profit and operating (loss) income are the measures used by the chief operating decision maker, identified as our President and Chief Executive Officer, to evaluate segment performance and identify opportunities when allocating resources.

The accounting principles applied at the reportable segment level in determining the segment measure of profit or loss are the same as those applied at the consolidated financial statement level. Sales and transfers between operating segments are accounted for at market-based transaction prices and are eliminated in consolidation.

Our U.S. operations include a facility in Alabama (primarily the distribution to customers of the bulk of our products and the light manufacturing of our chemical, wovens, reflective, and fire products) and facilities in Arizona, California, Colorado and Iowa (fire services). The Company also maintains one manufacturing facility in China (primarily disposable and chemical suit production), a manufacturing facility in Mexico (primarily disposable, reflective, fire and chemical suit production), a manufacturing facility in Vietnam (primarily disposable production), a manufacturing facility in Argentina (primarily wovens production), a manufacturing facility in Romania (boots), a manufacturing facility in New Zealand (helmets) and two small manufacturing facilities in India (primarily disposable and wovens production). Our China and Vietnam facilities produce a significant portion of the Company’s products. We evaluate the performance of these entities based on gross profit, which is defined as net sales less cost of goods sold, and operating income (loss), which is defined as income before income taxes, interest expense and other income and expenses. We have sales forces in the U.S., Canada, Mexico, Europe, Latin America, India, Russia, Kazakhstan, Australia, New Zealand and China, which sell and distribute products shipped from the U.S., Mexico, China, Vietnam or India.

The table below represents information about reportable segments for the three and six month periods noted therein (amounts may not foot due to rounding):


	Three Months Ended July 31,						Six Months Ended July 31,
(in millions of dollars)	2026			2025			2026			2025
Net Sales:
U.S. Operations	$	23.1		$	24.5		$	45.4		$	47.0
Other foreign		5.6			5.2			10.9			9.9
Europe		13.9			15.7			26.0			27.8
Mexico		1.9			2.0			4.4			3.8
Asia		15.3			14.3			26.3			26.3
Canada		2.6			2.9			4.7			5.3
Latin America		4.2			4.6			9.1			8.9
Less intersegment sales		(16.5	)		(16.7	)		(29.3	)		(29.8	)
Consolidated sales	$	50.1		$	52.5		$	97.5		$	99.2
External Sales:
U.S. Operations	$	21.3		$	22.1		$	41.4		$	42.8
Other foreign		3.7			3.3			7.2			6.3
Europe		12.4			15.1			23.8			26.9
Mexico		1.4			1.1			3.3			2.3
Asia		4.7			3.7			8.4			7.3
Canada		2.5			2.9			4.6			5.2
Latin America		4.1			4.3			8.8			8.4
Consolidated external sales	$	50.1		$	52.5		$	97.5		$	99.2
Intersegment Sales:
U.S. Operations	$	1.7		$	2.3		$	4.0		$	4.1
Other foreign		2.0			1.9			3.7			3.6
Europe		1.5			0.6			2.2			0.9
Mexico		0.7			0.9			1.2			1.5
Asia		10.5			10.7			17.9			19.1
Canada		0.1			0.1			0.1			0.2
Latin America		—			0.2			0.2			0.4
Consolidated intersegment sales	$	16.5		$	16.7		$	29.3		$	29.8

The table below represents information about reportable segments for the three and six month periods noted therein (amounts may not foot due to rounding):


	Three Months Ended July 31,						Six Months Ended July 31,
(in millions of dollars)	2026			2025			2026			2025
Cost of Goods Sold:
U.S. Operations	$	13.9		$	15.5		$	30.0		$	30.8
Other foreign		4.3			3.5			7.8			6.6
Europe		10.8			12.2			19.8			21.1
Mexico		2.3			2.1			4.7			3.9
Asia		11.7			11.4			20.9			21.0
Canada		1.7			2.0			3.0			3.9
Latin America		3.1			3.0			6.6			5.9
Less intersegment cost of goods sold		(16.2	)		(16.0	)		(28.7	)		(28.4	)
Consolidated cost of goods sold		31.6		$	33.7			64.1			64.8
Gross Profit:
U.S. Operations	$	9.2		$	9.0		$	15.4		$	16.2
Other foreign		1.3			1.7			3.1			3.2
Europe		3.0			3.5			6.1			6.7
Mexico		(0.5	)		(0.1	)		(0.4	)		(0.1	)
Asia		3.7			2.9			5.5			5.4
Canada		0.9			0.9			1.7			1.4
Latin America		1.1			1.6			2.5			3.0
Less intersegment loss		(0.2	)		(0.7	)		(0.5	)		(1.3	)
Consolidated gross profit		18.5		$	18.8			33.4			34.5
Operating Expenses:
U.S. Operations	$	11.0		$	10.7		$	21.7		$	21.4
Other foreign		1.4			1.6			2.9			3.0
Europe		3.7			3.4			7.0			7.4
Mexico		0.8			0.6			1.3			1.3
Asia		1.8			1.4			3.0			2.9
Canada		0.6			0.5			1.3			1.2
Latin America		1.5			1.4			3.0			3.0
Less intersegment operating expenses		(0.2	)		(0.4	)		(0.5	)		(0.7	)
Consolidated operating expenses	$	20.6		$	19.3			39.7			39.5
Settlement of lease liability, net:
U.S. Operations	$	(1.9	)		—		$	(1.9	)	$	—
Consolidated settlement of lease liability, net	$	(1.9	)	$	—		$	(1.9	)	$	—
Goodwill impairment:
Europe	$	3.2			—		$	3.2		$	—
Consolidated goodwill impairment expense	$	3.2		$	—		$	3.2		$	—
Gain on sale of certain assets:
U.S. Operations	$	—			—		$	(6.5	)	$	—
Consolidated gain on sale of certain assets	$	—		$	—		$	(6.5	)	$	—


Lease Impairment:
U.S. Operations	$	—			3.6		$	—		$	3.6
Consolidated lease impairment	$	—		$	3.6		$	—		$	3.6
Operating (Loss) Income:
U.S. Operations	$	0.1		$	(5.3	)	$	2.1		$	(8.9	)
Other foreign		(0.1	)		0.1			0.2			0.3
Europe		(3.9	)		0.1			(4.1	)		(0.7	)
Mexico		(1.2	)		(0.7	)		(1.7	)		(1.4	)
Asia		1.9			1.5			2.5			2.4
Canada		0.3			0.4			0.4			0.2
Latin America		(0.4	)		0.2			(0.5	)		—
Less intersegment loss (income)		—			(0.3	)		—			(0.6	)
Consolidated operating (loss) income	$	(3.3	)	$	(4.0	)	$	(1.1	)	$	(8.7	)

The table below represents information about reported segments as of the dates noted therein (amounts may not foot due to rounding):


	As of July 31,			As of January 31,
(in millions of dollars)	2026			2026
Total Assets:
U.S. Operations	$	168.4		$	170.4
Europe		51.9			61.1
Mexico		10.8			11.7
Asia		45.6			48.5
Canada		7.2			6.8
Latin America		24.2			23.6
Other foreign		19.5			19.8
Less intersegment		(121.1	)		(132.0	)
Consolidated assets	$	206.5		$	209.9
Total Assets Less Intersegment:
U.S. Operations	$	88.7		$	90.8
Europe		44.0			50.3
Mexico		7.4			8.2
Asia		25.4			20.8
Canada		3.2			2.9
Latin America		19.7			19.3
Other foreign		18.1			17.6
Consolidated assets	$	206.5		$	209.9
Total Goodwill and Intangible Assets
U.S. Operations	$	25.4		$	25.3
Europe		15.8			19.9
Other foreign		1.0			1.8
Consolidated goodwill and intangible assets	$	42.2		$	47.0

The table below presents external sales by product line:


	Three Months Ended July 31,				Six Months Ended July 31,
(in millions of dollars)	2026		2025		2026		2025
External Sales by product lines:
Disposables	$	14.1	$	13.9	$	27.7	$	27.0
Chemical		6.1		5.6		11.6		11.7
Fire Service		26.1		25.6		49.5		46.6
Gloves		0.4		0.4		0.7		0.7
High Visibility(1)		—		1.5		0.7		2.5
High Performance Wear(1)		—		2.2		0.9		3.8
Wovens		3.4		3.3		6.4		6.9
Consolidated external sales	$	50.1	$	52.5	$	97.5	$	99.2

(1) The Company sold inventory and intellectual property associated with the High Performance Wear and High Visibility clothing lines on March 27, 2026.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

The following discussion and analysis should be read in conjunction with the historical financial statements and other financial information included elsewhere in this quarterly report on Form 10-Q. This Form 10-Q may contain certain forward-looking statements. When used in this Form 10-Q or in any other presentation, statements which are not historical in nature, including the words “anticipate,” “estimate,” “should,” “expect,” “believe,” “intend,” “project,” “plan,” “seek,” “will,” “may,” “might,” “would,” “could” and similar expressions, are intended to identify forward-looking statements. They also include statements containing a projection of sales, earnings or losses, capital expenditures, dividends, capital structure or other financial terms.

The forward-looking statements in this Form 10-Q are based upon our management’s beliefs, assumptions and expectations of our future operations and economic performance, taking into account the information currently available to us. These statements are not statements of fact. Forward-looking statements involve risks and uncertainties, some of which are not currently known to us that may cause our actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial condition we express or imply in any forward-looking statements. Some of the important factors that could cause our actual results, performance or financial condition to differ materially from expectations are:

•

we are subject to risk as a result of our international manufacturing operations and are subject to the risk of doing business in foreign countries, particularly in China, Vietnam and India, including risks relating to the impacts of tariff policies and other trade maneuvers, which could affect our ability to manufacture or sell our products, obtain products from foreign suppliers or control the costs of our products;

•

a terrorist attack, other geopolitical crisis, or widespread outbreak of an illness or other health issue could negatively impact our domestic and/or international operations;

•

our results of operations could be negatively affected by potential fluctuations in foreign currency exchange rates;

•

our results of operations may vary widely from quarter to quarter;

•

disruption in our supply chain, manufacturing or distribution operations could adversely affect our business;

•

climate change and other sustainability matters may adversely affect our business and operations;

•

because we do not have long-term commitments from many of our customers, we must estimate customer demand, and errors in our estimates could negatively impact our inventory levels and net sales;

•

we face competition from other companies, a number of which have substantially greater resources than we do;

•

our operations are substantially dependent upon key personnel;

•

technological change could negatively affect sales of our products and our performance;

•

cybersecurity incidents could disrupt business operations, result in the loss of critical and confidential information and adversely impact our reputation and results of operations;

•

data privacy and security laws relating to the handling of personal information are evolving across the world and may be drafted, interpreted, or applied in a manner that results in increased costs, legal claims, fines against us, or reputational damage;

•

our success depends in part on our proprietary technology, and if we fail to obtain or enforce our intellectual property rights successfully, our competitive position may be harmed;

•

our inability to successfully identify, consummate and integrate current and future acquisitions and strategic investments or to realize anticipated cost savings and other benefits could adversely affect our business;

•

we are implementing a new enterprise resource planning system;

•

we have identified a material weakness in our internal control over financial reporting;

•

covenants in our credit facilities may restrict our financial and operating flexibility;

•

we may need additional funds, and if we are unable to obtain these funds, we may not be able to expand or operate our business as planned;

•

adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our business, financial condition or results of operations;

•

we are subject to certain U.S. and foreign anti-corruption laws and other laws and regulations as a result of our international operations;

•

we are exposed to U.S. and foreign tax risks;

•

we may be subject to product liability claims, and insurance coverage could be inadequate or unavailable to cover these claims;

•

environmental laws and regulations may subject us to significant liabilities;

•

provisions in our restated certificate of incorporation and by-laws and Delaware law could make a merger, tender offer or proxy contest difficult; and

•

the other factors referenced in this Form 10-Q, including, without limitation, in the sections entitled “Part I – Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the factors described under “Risk Factors” disclosed in our fiscal 2026 Form 10-K.

We believe these forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements that are based on current expectations. Furthermore, forward-looking statements speak only as of the date they are made. We undertake no obligation to publicly update or revise any forward-looking statements after the date of this Form 10-Q, whether as a result of new information, future events or otherwise, except as may be required by law. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this Form 10-Q might not occur. We qualify any and all of our forward-looking statements entirely by these cautionary factors.

Business Overview

We manufacture and sell a comprehensive line of industrial protective clothing and accessories for the industrial and public protective clothing market. In addition, we provide decontamination, repair and rental services that complement our fire services portfolio. Our products are sold globally by our in-house sales teams, our customer service group, and to a strategic and selective global network of authorized distribution partners. Our authorized distributors supply end users across various industries, including integrated oil, chemical/petrochemical, automobile, transportation, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical and high-tech electronics manufacturers, as well as scientific, medical laboratories and the utilities industry. We also supply federal, state and local governmental agencies and departments, including fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control. Internationally, we sell to a mixture of end-users directly and to industrial distributors, depending on the particular country and market. In addition to the U.S., sales are made into more than 50 foreign countries, the majority of which are into China, the European Economic Community ("EEC"), Canada, Chile, Argentina, Russia, Kazakhstan, Colombia, Mexico, Ecuador, India, Uruguay, Middle East, Southeast Asia, New Zealand, Australia and Hong Kong.

The Company’s strong market position across its focus product categories and markets is supported by continued and increasing investment in its global footprint, particularly owning and operating its own manufacturing facilities, acquiring complementary companies or products that expand and enhance product offerings and/or geographic customer territories and investing in sales and marketing resources in countries around the world. We believe that ownership of manufacturing is the cornerstone of building a resilient supply chain and providing high-quality products to our customers. Having ten manufacturing locations in eight countries on five continents, and sourcing core raw materials from multiple suppliers in various countries affords Lakeland superior manufacturing capabilities and supply chain resilience compared to our competitors who use contractors. Additionally, our focus on providing customers with best-in-class service includes the strategic location of our sales team members.

Lakeland is committed to protecting the world’s workers, first responders, and communities while creating value for its shareholders. Key elements of our corporate strategy include:

•

Creating a high-performance culture driven by our corporate values,

•

Investing resources in high-growth geographies and product categories,

•

Building a premier global firefighter safety brand through product and marketing enhancements,

•

Driving profitable growth in high-end chemical and limited-use/disposable protective clothing through product development, strategic pricing initiatives, channel diversification, and operations optimization, and

•

Acquiring companies that improve Lakeland’s competitive advantage in focus markets.

We sold our high performance FR/AR apparel line and our high visibility clothing line on March 27, 2026.

Our net sales attributable to customers outside the U.S. were $28.7 million and $30.4 million for the three months ended July 31, 2026 and 2025, respectively, and $56.0 million and $56.4 million for the six months ended July 31, 2026 and 2025, respectively.

Key Trends Affecting Our Operations

Trade Policies and Regulations

Since early 2025, the executive branch of the U.S. government has pursued a policy of imposing tariffs on imports from many foreign countries, including countries where the Company has manufacturing facilities, such as China, India, and Vietnam, among others. In response, China and other countries announced retaliatory tariffs against certain U.S. imports. These tariffs have been, and may continue to be, announced, amended, paused, reinstated and rescinded with little or no advance notice. On February 20, 2026, the U.S. Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act (“IEEPA”), and the U.S. Court of International Trade (“CIT”) subsequently ordered U.S. Customs and Border Protection to process refunds of tariffs paid under the IEEPA. While we have submitted claims for refunds related to certain eligible tariffs paid, the ultimate availability, timing, and amount of any potential refunds of such tariffs remain uncertain and are subject to further legal, regulatory, and administrative developments. During the six months ended July 31, 2026, the Company received approximately $2.1 million of refunds related to previously paid IEEPA tariffs. The tariff refunds were recorded in the condensed consolidated financial statements as a reduction to cost of goods sold.

After the Supreme Court’s ruling on the IEEPA tariffs, the Trump Administration immediately imposed new global tariffs pursuant to Section 122 of the Trade Act of 1974, which allows for tariffs of up to 15% for a period of up to 150 days, and indicated its intention to consider other legal options for imposing tariffs. However, in May 2026, the CIT held that the tariffs imposed under Section 122 were unlawful. This ruling has been appealed and is subject to ongoing litigation. Subsequently, the Trump Administration imposed new tariffs on imports from more than 80 countries at varying rates under a number of different statutory provisions, including Section 301 of the Trade Act of 1974 and Section 338 of the Tariff Act of 1930.

The extent and duration of increased tariffs and the resulting impact on general economic conditions and on our business are uncertain. As the situation remains fluid due to the rapidly changing global trade environment, we continue to evaluate the potential implications of these actions on our business, and we are uncertain about the ultimate impact that these policies will have on our business. Thus far, however, they have increased the cost of importing certain products, which has affected our operating results and margins. In prior years, the Company has been able to pass along a portion of costs resulting from tariffs to its customers, but there is no guarantee that we will be able to successfully do so in the future. Therefore, we expect that, as long as such tariffs are in effect, they will continue to affect our operating results and margins, and as a result, our historical and current gross profit margins may not be indicative of our gross profit margins for future periods. We will mitigate these factors to the best of our abilities through supply chain and manufacturing site initiatives. However, where annualized cost increases cannot be eliminated, strategic market price adjustments will be implemented.

Russia-Ukraine Conflict

We are continually monitoring the potential financial impact of the Russian invasion of Ukraine on our operations. For the six months ended July 31, 2026, sales in Russia accounted for approximately 2.1% of our consolidated sales, and sales into Ukraine were not significant. We do not have any capital assets in Russia.

Conflict in the Middle East

We are continually monitoring the potential financial impact of the U.S. and Israel coordinated military operation against Iran on our operations. Our sales in the Middle East were not significant during the six months ended July 31, 2026. However, ongoing supply chain disruptions or increased freight costs resulting from the reduction in shipping volume through the Strait of Hormuz could have material adverse effects on our business.

Results of Operations

Three Months ended July 31, 2026, Compared to the Three Months Ended July 31, 2025

Net Sales. Net sales were $50.1 million for the three months ended July 31, 2026, a decrease of $2.4 million or 4.5%, compared to $52.5 million for the three months ended July 31, 2025. The decrease primarily reflected the absence of sales from our High Performance Wear and High Visibility product lines, which were sold in the first quarter of FY27. This decrease was partially offset by higher sales across the remaining product lines, including increases of $0.5 million in Fire Service products, $0.5 million in Chemical products, $0.2 million in Disposable products and $0.1 million in Woven products.

Gross Profit. Gross profit for the three months ended July 31, 2026 was $18.5 million, a decrease of $0.3 million, or 1.5%, compared to $18.8 million for the three months ended July 31, 2025. Gross profit as a percentage of net sales increased to 37.0% for the three months ended July 31, 2026, from 35.8% for the three months ended July 31, 2025, primarily due to $2.1 million in tariff refunds received related to previously paid import duties, as well as lower labor, production and material costs. These impacts were partially offset by increased rent, new tariffs and freight costs.

Operating Expenses. Operating expenses increased by $1.3 million, or 7.0%, from $19.3 million for the three months ended July 31, 2025 to $20.6 million for the three months ended July 31, 2026. The increase was primarily due to currency fluctuations, tradeshow, advertising and amortization expenses, partially offset by decreases in stock based compensation, incentive compensation and professional fees. Operating expenses as a percentage of net sales were 41.2% for the three months ended July 31, 2026, up from 36.7% for the three months ended July 31, 2025, primarily due to the factors noted above.

Settlement of lease liability, net. In July 2026, the Company reached a settlement with the landlord of the Monterrey, Mexico facility that terminated the Monterrey lease in its entirety and concluded the related litigation. During the three months ended July 31, 2026, the Company released the remaining lease liability and recognized a gain of approximately $1.9 million.

Goodwill Impairment. During the three months ended July 31, 2026, the Company recognized a goodwill impairment of $3.2 million related to the LHD reporting unit within the Europe geographic segment, representing the remaining goodwill associated with this reporting unit. No goodwill remains allocated to this reporting unit.

Lease Impairment. During the three months ended July 31, 2025, the Company recorded a $3.6 million impairment primarily related to the right-of-use asset for the Monterrey, Mexico facility. There were no lease impairment charges recorded for the three months ended July 31, 2026.

Operating Loss. Operating loss was $(3.3) million for the three months ended July 31, 2026, compared to an operating loss of $(4.0) million for the three months ended July 31, 2025, due to the impacts detailed above. Operating margins were (6.7)% for the three months ended July 31, 2026, as compared to (7.7)% for the three months ended July 31, 2025.

Income Tax Expense (Benefit). Income tax expense (benefit) consists of federal, state and foreign income taxes. Income tax expense was $1.2 million for the three months ended July 31, 2026, compared to a benefit of $(5.2) million for the three months ended July 31, 2025. The Company's effective tax rate for the second quarter of FY26 was a tax expense of 32.4% which differs from the U.S. federal statutory rate of 21% primarily as a result of a valuation allowance against the Company’s U.S. operations.

Net (Loss) Income. Net loss was $(4.9) million for the three months ended July 31, 2026, compared to a net income of $0.8 million for the three months ended July 31, 2025.

Six Months ended July 31, 2026, Compared to the Six Months Ended July 31, 2025

Net Sales. Net sales were $97.6 million for the six months ended July 31, 2026, a decrease of $1.6 million or 1.7%, compared to $99.2 million for the six months ended July 31, 2025. The decrease primarily reflected the lower sales from the High Performance Wear and High Visibility product lines, which were sold in the first quarter of FY27. This decrease was partially offset by an increase in sales of $2.9 million in Fire Service products and $0.7 million in Disposable products. Sales of Woven and Chemical products decreased by $0.5 million and $0.1 million, respectively, while sales of Glove products remained consistent.

Gross Profit. Gross profit for the six months ended July 31, 2026 was $33.4 million, a decrease of $1.1 million, or 3.0%, compared to $34.5 million for the six months ended July 31, 2025. Gross profit as a percentage of net sales decreased to 34.3% for the six months ended July 31, 2026, from 34.7% for the six months ended July 31, 2025, primarily due to increased labor, rent, new tariffs, freight and certification costs. These impacts were partially offset by $2.1 million in tariff refunds received related to previously paid import duties, as well as lower production and material costs.

Operating Expenses. Operating expenses increased by $0.1 million, or 0.4%, to $39.7 million for the six months ended July 31, 2026 from $39.6 million for the six months ended July 31, 2025. The increase was primarily due to currency fluctuations, tradeshow, advertising and amortization expenses, partially offset by decreases in labor, incentive compensation, professional fees and stock based compensation. Operating expenses as a percentage of net sales were 40.7% for the six months ended July 31, 2026, an increase from 39.9% for the six months ended July 31, 2025, primarily due to the factors noted above.

Goodwill Impairment. During the six months ended July 31, 2026, the Company recognized a goodwill impairment of $3.2 million related to the LHD reporting unit within the Europe geographic segment, representing the remaining goodwill associated with this reporting unit. No goodwill remains allocated to this reporting unit.

Settlement of lease liability, net. In July 2026, the Company reached a settlement with the landlord of the Monterrey, Mexico facility that terminated the Monterrey lease in its entirety and concluded the related litigation. During the six months ended July 31, 2026, the Company released the remaining lease liability and recognized a gain of approximately $1.9 million.

Gain on Sale of Certain Assets. On March 27, 2026, the Company completed the sale of High Performance and High Visibility inventory and intellectual property to an unrelated third party for $14.0 million yielding $13.2 million in cash proceeds after inventory adjustments. The Company, for a six-month period, will manufacture and ship such inventory on behalf of the buyer; accordingly, any gain associated with such inventory and the related profit has been deferred and will be recognized over the six-month contract period.

Lease Impairment. During the six months ended July 31, 2025, the Company recorded a $3.6 million impairment primarily related to the right-of-use asset for the Monterrey, Mexico facility. There were no lease impairment charges recorded for the six months ended July 31, 2026.

Operating Loss. Operating loss was $(1.1) million for the six months ended July 31, 2026, compared to an operating loss of $(8.7) million for the six months ended July 31, 2025, due to the impacts detailed above. Operating margins were (1.1)% for the six months ended July 31, 2026, as compared to (8.7)% for the six months ended July 31, 2025.

Income Tax Expense (Benefit). Income tax expense consists of federal, state and foreign income taxes. Income tax expense was $2.6 million for the six months ended July 31, 2026, compared to a benefit of $6.4 million for the six months ended July 31, 2025. The Company's effective tax rate was a tax expense of 127.0% for the six months ended July 31, 2026 and a tax benefit of 67.1% for the six months ended July 31, 2025 which differs from the U.S. federal statutory rate of 21% primarily as a result of a valuation allowance against the Company’s U.S. operations.

Net (Loss) Income. Net loss was $(4.6) million for the six months ended July 31, 2026, compared to a net loss of $(3.1) million for the six months ended July 31, 2025.

Liquidity and Capital Resources

At July 31, 2026, cash and cash equivalents were approximately $17.9 million, and working capital was approximately $90.8 million. Cash and cash equivalents increased $5.4 million, and working capital decreased $5.4 million, from January 31, 2026 due to the balance sheet fluctuations described below.

Of the Company’s total cash and cash equivalents of $17.9 million as of July 31, 2026, cash held in Latin America of $1.2 million, cash held in the UK of $1.1 million, cash held in Russia and Kazakhstan of $2.8 million, cash held in the EEC of $3.9 million, cash held in India of $0.6 million, cash held in Vietnam of $1.2 million, and cash held in Hong Kong of $0.4 million would not be subject to additional U.S. tax in the event such cash was repatriated due to the change in the U.S. tax law as a result of the December 22, 2017 enactment of the 2017 Tax Cuts and Jobs Act (the “Tax Act”). When the Company repatriates cash from China, of the $3.0 million balance at July 31, 2026, an additional 10% withholding tax may be incurred in that country. The Company expects to repatriate cash from China during FY 27 and in anticipation of doing so, has accrued withholding tax expense of $0.3 million as of July 31, 2026.

Cash provided by operations was $5.4 million. Net loss of $(4.6) million for the six months ended July 31, 2026 was adjusted for non-cash charges of $(1.2) million, primarily related to the gains on sale of inventory and intellectual property associated with our high performance and high visibility product lines and lease termination and settlement of the Monterrey, Mexico facility, partially offset by the goodwill impairment of the LHD reporting unit. There was an increase in operating assets and liabilities of $11.2 million primarily related to changes in inventory, deferred revenue and accounts payable. Net cash provided by investing activities was $3.6 million, primarily due to the proceeds from the sale of the high-visibility and high-performance workwear styles partially offset by purchases of capital equipment. Net cash used in financing activities was $3.5 million due to $30.3 million borrowed under our credit facility to fund working capital increases offset by the repayment of debt facilities of $33.9 million and $0.2 million in shares returned to pay income taxes on shares vested under our equity compensation program.

We believe our current cash, cash equivalents, borrowing capacity under our Loan Agreement, and the cash to be generated from expected product sales will be sufficient to meet our projected operating and investing requirements (including planned capital expenditures) for at least the next twelve months. However, our liquidity assumptions may prove to be incorrect, and we may need to utilize our available financial resources sooner than we currently expect.

On June 25, 2020, the Company entered into a Loan Agreement (the “Original Loan Agreement”) with Bank of America, N.A. (“Lender”), as amended by Amendment No. 1 to the Loan Agreement, dated June 18, 2021 (“Amendment No. 1”), Amendment No. 2 to the Loan Agreement, dated March 3, 2023 (“Amendment No. 2”), Amendment No. 3 to the Loan Agreement, dated November 30, 2023 (“Amendment No. 3”), Amendment No. 4 to the Loan Agreement, dated March 28, 2024 (“Amendment No. 4”), Amendment No. 5 to the Loan Agreement, dated December 12, 2024 (“Amendment No. 5”) and Amendment No. 6 to the Loan Agreement, dated July 7, 2025 (“Amendment No. 6” and, collectively with Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, and Amendment No. 5, the “Loan Agreement Amendments”; and the Original Loan Agreement, as amended by the Loan Agreement Amendments, the “Amended Loan Agreement”).

On April 13, 2026, the Company and the Lender entered into a limited waiver (the “Limited Waiver”), pursuant to which the Lender waived the Company’s non-compliance as of January 31, 2026 with respect to two financial covenants under the Amended Loan Agreement. The $40.0 million aggregate commitment amount of the Amended Loan Agreement, maturity date of December 12, 2029, and applicable interest rate of the Amended Loan Agreement remained unchanged. The Company was in compliance with all of its debt covenants as of July 31, 2026.

Borrowings under the revolving credit facility bear interest at a rate per annum equal to the sum of (i) the greater of the daily Secured Overnight Financing Rate (“SOFR”) or an index floor of 1% plus (ii) the Applicable Rate (as defined in the Amended Loan Agreement). The Applicable Rate is based on a funded debt-to-EBITDA ratio (discussed below) and includes four different levels, constituting a SOFR margin range of 1.25% to 2.00%. All outstanding principal and unpaid accrued interest under the revolving credit facility are due and payable on the maturity date. On a one-time basis, and subject to there not existing an event of default, the Company may elect to convert up to $5.0 million of the then outstanding principal of the revolving credit facility to a term loan facility with an assumed amortization of 15 years and the same interest rate and maturity date as the revolving credit facility. The Amended Loan Agreement provides for a fee on any difference between the line of credit commitment and the amount of credit it actually uses, determined by the daily amount of credit outstanding during the specified period. Such fee is calculated at the Applicable Rate and is payable quarterly.

Stock Repurchase Program. On April 7, 2022, the Board of Directors authorized a stock repurchase program under which the Company may repurchase up to $5.0 million of its outstanding common stock, which became effective upon the completion of a prior share repurchase program. On December 1, 2022, the Board of Directors authorized an increase in the Company’s stock repurchase program, under which the Company may repurchase up to an additional $5.0 million of its outstanding common stock.

No shares were repurchased in the six months ended July 31, 2026, leaving $5.0 million remaining under the share repurchase program at July 31, 2026. The share repurchase program has no expiration date but may be terminated by the Board of Directors at any time.

Capital Expenditures. Our capital expenditures were $1.4 million for the six months ended July 31, 2026 which primarily relates to replacement equipment for our manufacturing sites and equipment for our greenfield ISPs. We expect to fund the capital expenditures from our cash flows from operations. The Company may also expend funds in connection with potential acquisitions.

Critical Accounting Policies and Estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. A summary of our significant accounting policies is included in Note 1 to our consolidated financial statements in our fiscal year 2026 Form 10-K. Certain of our accounting policies are considered critical, as these policies are the most important to the depiction of our financial statements and require significant, difficult, or complex judgments, often employing the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section in our 2026 Form 10-K. There have been no significant changes in the application of our critical accounting policies and estimates during the six months ended July 31, 2026.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

A smaller reporting company is not required to provide the information required by this Item, and therefore, no disclosure is required under Item 3 for the Company.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of July 31, 2026. The term “disclosure controls and procedures” means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive officer and principal financial officer have concluded that as of July 31, 2026, our disclosure controls and procedures were not effective due to the material weakness in internal control over financial reporting described below.

Notwithstanding the ineffective disclosure controls and procedures as a result of the identified material weakness described below, management has concluded that the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q present fairly, in all material respects, the Company’s financial position, results of operations and cash flows in accordance with U.S. GAAP.

Material Weakness in Internal Control over Financial Reporting

As previously disclosed in our 2026 Form 10-K, management identified certain deficiencies in the Company’s internal control over financial reporting that aggregated to a material weakness related to the completeness and accuracy of its foreign reporting packages. Specifically, the Company has undergone significant changes in size, complexity and geographic footprint primarily due to multiple acquisitions, and has numerous systems that process financially relevant data. Of these systems, Sage X3 (United States, Canada and the United Kingdom) and Kingdee (China and Hong Kong), were in the Company’s scope for testing of information technology general controls (“ITGCs") in support of management’s assessment of internal control over financial reporting. The Company’s consolidation process is manual and based upon reporting packages submitted by the various locations. For those locations where the financially relevant systems were not in-scope and not subject to the Company’s testing of ITGCs, the financial reporting controls, as designed, do not adequately address the completeness and accuracy of the foreign reporting packages. The reporting packages form the basis of multiple controls, including a key management review control designed to detect a material misstatement in the Company’s consolidated financial statements as well as other controls. Additionally, the Company did not update the control activities documentation for numerous locations and, in some cases, did not change control processes to reflect changes in operating structure. This contributed to the material weakness disclosed in our 2026 Form 10-K in the Company’s internal controls.

Management’s Remediation Plan and Status

In response to the material weakness, management has taken, or is in the process of taking, the following actions:

•

Implementing an enterprise resource planning (“ERP”) system, which is expected to roll out in phases over the next several years.

•

Tasked the Audit Committee of the Board of Directors with oversight of the risks associated with the Company's technology strategies, its major technology investments and its operational performance; and

•

Migrating substantially all of our operations to a common accounting system and utilizing a common chart of accounts and improved accounting close and revise procedures.

While some of these measures have been completed as of the date of this report, management has not completed and tested all of the planned corrective processes, enhancements, procedures and related evaluation necessary to determine whether the material weakness has been fully remediated. Moreover, the corrective actions and controls need to be in operation for a sufficient period of time for management to conclude that the control environment is operating effectively and has been adequately tested by management. Accordingly, the material weakness has not been fully remediated as of the date of this report. As the Company continues its evaluation and remediation efforts, management may modify the actions described above or identify and take additional measures to address the material weakness. Management will continue to assess the effectiveness of remediation efforts in connection with its ongoing evaluation of internal control over financial reporting.

Changes in Internal Control Over Financial Reporting

Other than continuing to make progress on the ongoing remediation efforts described above, there were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended July 31, 2026 that materially affected, or are reasonably likely to affect materially, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are subject to a variety of litigation and other legal proceedings and claims incidental to our business. Based upon our experience, current information and applicable law, we do not believe that these proceedings and claims will have a material adverse effect on our results of operations, financial condition or cash flows. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to our results of operations, financial condition or cash flows. For additional information, please see Note 11 to our consolidated financial statements in this Form 10-Q.

Item 1A. Risk Factors

We are subject to risk as a result of our international manufacturing operations, including risks resulting from recent developments in the international trade environment, such as increased import tariffs.

Because most of our products are manufactured at our facilities located in China, Vietnam, Mexico, Argentina, New Zealand, Romania and India, our operations are subject to risks inherent in doing business internationally. Such risks include the adverse effects on operations from corruption, war, international terrorism, civil disturbances, political instability, trade wars, government activities such as border taxes and renegotiation of treaties, deprivation of contract and property rights and currency valuation changes. Based on the complex relationships between China and the U.S., there is an inherent risk that political, diplomatic, military, or other events could result in business disruptions, including increased regulatory enforcement against companies, tariffs, trade embargoes, and export restrictions.

In recent years, the U.S. has imposed tariffs on various products imported into the U.S. These tariffs have resulted in, and may continue to trigger, retaliatory actions by affected countries, including the imposition of tariffs on the U.S. by other countries. Under the current administration, trade policy has been a central focus, with renewed scrutiny on trade relationships with China and efforts to renegotiate or withdraw from key agreements such as the United States-Mexico-Canada Agreement (USMCA). This shift has included the introduction of additional tariffs, including on Mexican, Canadian, Chinese, Vietnamese, European Union and Indian goods, targeted sanctions, and restrictions on investments linked to industries deemed critical to U.S. national security. Certain foreign governments, such as China, Canada, Mexico and the European Union, have instituted or are considering imposing trade sanctions on certain U.S. goods and denying U.S. companies access to critical raw materials.

The extent and duration of increased tariffs, which we are unable to predict, and the resulting impact on general economic conditions and on our business are uncertain and depend on various factors, such as negotiations between the U.S. and affected countries, the responses of other countries or regions, exemptions or exclusions that may be granted, availability and cost of alternative sources of supply, and demand for our products in affected markets. For example, in 2025, the U.S. widely imposed tariffs under the International Emergency Economic Powers Act, which tariffs were subsequently held invalid by the U.S. Supreme Court. Following the Supreme Court’s ruling, the Trump Administration imposed new global and country- and good-specific tariffs pursuant to other legal authorities and indicated its intention to continue to pursue a trade policy heavily reliant on tariffs.

Our business has been negatively affected by the recent international tariff and trade environment and may be negatively affected in the future by the quickly evolving tariff situation and the economic uncertainty created thereby. Tariffs increase the cost of our products and the components and raw materials that go into making them. These increased costs adversely impact the gross margin we earn on our products. Tariffs have also increased the cost of our products for customers, making them less competitive and have resulted in reduced consumer demand. Countries may also adopt other measures, such as controls on imports or exports of goods, technology, or data, that could adversely impact the Company’s operations, strategy and supply chain and limit the Company’s ability to offer our products and services. These measures can require us to take various actions, including changing suppliers, shifting production of certain products to lower-tariff countries and restructuring business relationships. Changing our operations in accordance with new or changed trade restrictions can be expensive, time-consuming, and disruptive to our operations, as well as distracting to management. Such restrictions have been, and may be in the future, announced, amended, paused, reinstated, or rescinded with little or no advance notice, and we may not be able to effectively mitigate all adverse impacts from such measures. Uncertainty surrounding trade and other international disputes has had a negative effect on consumer confidence and spending, and we cannot predict how long such uncertainty may last. These events have reduced customer demand, and additional tariff policies could exacerbate those effects, increase the cost of our products and services, or otherwise have a materially adverse impact on our customers’ and suppliers’ businesses and results of operations, which could in turn additionally adversely impact our financial performance and growth prospects.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

On July 25, 2026, we completed the issuance of 7,500 restricted stock units (“RSUs”) to MZHCI, LLC (“MZ Group”) pursuant to an investor relations consulting agreement by and between the Company and MZ Group entered into on October 4, 2024 (the “Consulting Agreement”). The RSUs are fully vested. The issuance of these securities was effected without registration in reliance on Section 4(a)(2) of the Securities Act as a sale by the Company not involving a public offering. No underwriters were involved with the issuance of such securities.

Issuer Purchases of Equity Securities

On April 7, 2022, the Board of Directors authorized a stock repurchase program under which the Company may repurchase up to $5.0 million of its outstanding common stock (the “Share Repurchase Program”). The Share Repurchase Program became effective upon the completion of a prior Share Repurchase Program. The Share Repurchase Program has no expiration date; however, it may be terminated by the Board of Directors at any time. On December 1, 2022, the Board of Directors authorized an increase in the Share Repurchase Program under which the Company may repurchase up to an additional $5.0 million of its outstanding common stock.

The common shares available for repurchase under the authorizations currently in effect may be purchased from time to time, with consideration given to the market price of the common shares, the nature of other investment opportunities, cash flows from operations, general economic conditions and other relevant considerations. Repurchases may be made on the open market or through privately negotiated transactions.

The following table sets forth purchases made by or on behalf of the Company or any “affiliated purchaser,” as defined in Rule 10b-18(a)(3) of the Exchange Act, of shares of the Company’s common stock during the second quarter of fiscal 2027:


Period	Total Number of Shares Purchased		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs		Maximum Dollar Amount of Shares that May Yet Be Purchased Under the Programs (1)
May 1 – May 31		—	$	—		—	$	5,030,479
June 1 – June 30		—	$	—		—	$	5,030,479
July 1 – July 31		—	$	—		—	$	5,030,479
Total		—	$	—		—	$	5,030,479

(1)

Represents the amount remaining under our share repurchase program as of July 31, 2026.

Item 5. Other Information

Rule 10b5-1 Trading Plans

From time to time, members of the Company’s Board of Directors and officers of the Company may enter into Rule 10b5-1 trading plans, which allow for the purchase or sale of common stock under pre-established terms at times when directors and officers might otherwise be prevented from trading under insider trading laws or because of self-imposed blackout periods. Such trading plans are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and comply with the Company’s insider trading policy. Other than as described below, during the three months ended July 31, 2026, none of the Company’s directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

On July 2, 2026, Thomas McAteer, a member of the Board of Directors of the Company, adopted a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “Rule 10b5-1 Plan”). Mr. McAteer’s plan, which provides for the potential sale of up to 10,000 shares of the Company's common stock, terminates upon the earlier of April 1, 2028 or the date all shares subject to the plan have been sold.

Item 6. Exhibits

* Filed herewith

† Management contract or compensatory plan or arrangement

‡ Furnished herewith


3.1	Restated Certificate of Incorporation of Lakeland Industries, Inc., as amended (incorporated by reference to Exhibit 4.1 of Lakeland Industries, Inc.’s Registration Statement on Form S-8 filed on September 3, 2021)

3.2	Amended and Restated Bylaws of Lakeland Industries Inc. (incorporated by reference to Exhibit 3.1 of Lakeland Industries, Inc.’s Form 8-K filed April 28, 2017)

10.1†	Lakeland Industries, Inc. 2026 Equity Incentive Plan (incorporated by reference to Exhibit 4.3 to Lakeland Industries, Inc.’s Registration Statement on Form S-8 (File No. 333-296827) filed with the Commission on June 16, 2026)

31.1*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15(d)-14(a) under the Securities Exchange Act of 1934

31.2*	Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or 15(d)-14(a) under the Securities Exchange Act of 1934

32.1‡	Certification of Chief Executive Officer as adopted pursuant to 18 U.S.C. Section 1350 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2‡	Certification of Principal Financial Officer as adopted pursuant to 18 U.S.C. Section 1350 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101*	The following financial statements from the Quarterly Report on Form 10-Q for the quarter ended July 31, 2026, formatted in Inline XBRL: (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive (Loss) Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to the Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.

104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	LAKELAND INDUSTRIES, INC. (Registrant)


Date: September 9, 2026	/s/ James M. Jenkins
	James M. Jenkins, Chief Executive Officer, President and Executive Chairman (Principal Executive Officer and Authorized Signatory)


Date: September 9, 2026	/s/ J. Calven Swinea
	J. Calven Swinea, Chief Financial Officer and Secretary (Principal Financial Officer and Authorized Signatory)